Emergent BioSolutions

Emergent BioSolutions

Emergent BioSolutions

Emergent is a global specialty biopharmaceutical company offering specialized products that address medical needs and emerging health threats.
Founded
1998
Follow us
Alexa global traffic share
Twitter followers
Team Size
1000+
Employees
Pulse 2.0

Johnson & Johnson (JNJ) Partners With Emergent Biosolutions (EBS) On COVID-19 Vaccine

FinSMEs

Emergent BioSolutions to Acquire Vaccines Company PaxVax, for $270M

Health
Technical.ly

Emergent Biosolutions plans $50M expansion at Baltimore facility

Technical.ly

Emergent Biosolutions will move manufacturing of anthrax treatment to Baltimore Baltimore

Health
Technical.ly

Emergent Biosolutions doubles size of vaccine manufacturing operation in Bayview Baltimore

Health City life
The Motley Fool

Why Emergent BioSolutions Inc. Procured a Lower Price Today

The Motley Fool

Emergent BioSolutions Inc in Transition

Health
The Motley Fool

Emergent BioSolutions Inc. Expanding Along

Earnings People Stock markets